Two Sigma Investments’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
71,537
-14,817
| -17% | -$21.9K | ﹤0.01% | 2942 |
|
|
2025
Q1 | $221K | Buy |
+86,354
| New | +$221K | ﹤0.01% | 2764 |
|
|
2024
Q1 | – | Sell |
-19,600
| Closed | -$34.9K | – | 3209 |
|
|
2023
Q4 | $34.9K | Sell |
19,600
-27,700
| -59% | -$49.3K | ﹤0.01% | 2936 |
|
|
2023
Q3 | $78.5K | Sell |
47,300
-7,825
| -14% | -$13K | ﹤0.01% | 2689 |
|
|
2023
Q2 | $110K | Sell |
55,125
-138,969
| -72% | -$278K | ﹤0.01% | 2663 |
|
|
2023
Q1 | $408K | Buy |
194,094
+183,968
| +1,817% | +$386K | ﹤0.01% | 2223 |
|
|
2022
Q4 | $13.9K | Sell |
10,126
-225
| -2% | -$308 | ﹤0.01% | 2651 |
|
|
2022
Q3 | $11K | Sell |
10,351
-15,159
| -59% | -$16.1K | ﹤0.01% | 2365 |
|
|
2022
Q2 | $28K | Buy |
+25,510
| New | +$28K | ﹤0.01% | 2314 |
|
|
2015
Q1 | – | Sell |
-4,021
| Closed | -$74K | – | 2322 |
|
|
2014
Q4 | $74K | Buy |
4,021
+1,139
| +40% | +$21K | ﹤0.01% | 2147 |
|
|
2014
Q3 | $70K | Sell |
2,882
-912
| -24% | -$22.2K | ﹤0.01% | 1683 |
|
|
2014
Q2 | $138K | Buy |
+3,794
| New | +$138K | ﹤0.01% | 2027 |
|
|
2014
Q1 | – | Sell |
-5,357
| Closed | -$208K | – | 2199 |
|
|
2013
Q4 | $208K | Buy |
5,357
+3,487
| +186% | +$135K | ﹤0.01% | 2001 |
|
|
2013
Q3 | $85K | Sell |
1,870
-1,726
| -48% | -$78.5K | ﹤0.01% | 1761 |
|
|
2013
Q2 | $177K | Buy |
+3,596
| New | +$177K | ﹤0.01% | 1805 |
|